24.08.2015 • News

Rayonier and Eastman Sue Each Other Over Specialty Cellulose Supply Agreement

Rayonier Advanced Materials has filed a lawsuit against Eastman Chemical in a dispute over their purchase and supply agreement for specialty cellulose products. The action, which calls for a judgement against Eastman, was filed in a court in Georgia, USA, on August 13 and disclosed in an 8-K filing with the Securities and Exchange Commission (SEC).

Specifically, Rayonier is seeking a legal interpretation of certain aspects of the agreement which affect the price and, in some cases, the volume required to be purchased by Eastman. The agreement, effective from January 1, 2012, runs through 2018. The dispute relates to 2016 and future contract years.

The primary language at issue involves the “meet or release” provisions which allow Eastman to obtain bona fide third-party offers that meet the requirements of the supply agreement for similar specialty cellulose products, thus requiring Rayonier to either meet such price or release the volume. Rayonier said it strongly believes that the language of the agreement, as well as past practice by the parties, make clear that the volume subject to this provision is limited to 7,500 t/y which is less than 2% of its total expected specialty cellulose sales to all of Rayonier’s customers in 2015.

Eastman has filed an action in Tennessee in which it asserts that its entire annual purchase obligation is subject to the “meet or release” provision, rather than only 7,500 t/y.

Chairman, president and CEO of Rayonier, Paul Boynton, commented: “Pricing negotiations are always spirited debates around a number of factors and threatened or actual litigation is one tool that parties can employ. Although Rayonier Advanced Materials would have preferred to address any concerns or negotiations around pricing privately, Eastman’s August 4 action required us to take the necessary steps to protect our contractual arrangement.”

He added: “We remain committed to resolving our differences with our largest customer in a constructive manner and continuing our 85 year relationship, which has been mutually beneficial to both parties, for many years to come.”

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.